Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-76.94	8.26	35.80
Graham Fair Price	-43.23	1.59	2.80
PEG	138.47	-0.14	0.06
Price/Book	-8.91	5.42	5.95
Price/Cash Flow	85.94	-0.28	-1.99
Prices/Earnings	186.74	17.73	-6.18
Price/Sales	14.42	1.47	1.29
Price/FCF	85.94	-0.28	-1.99
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	56.51	1.36	0.87
Operating Margin	47.69	0.67	0.46
ROA	-70.09	< 0.005	< 0.005
ROE	-0.24	0.08	-68.23
ROIC	0.03	0.11	308.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.72	0.12	502.30
Dividends QOQ	< 0.005	< 0.005	297.91
EBIT QOQ	-0.40	0.19	-51.74
EPS QOQ	-1.09	1.31	20.24
FCF QOQ	-1.99	-5.57	-180.18
Revenue QOQ	-0.23	-0.19	17.31
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-38.59	-1026.64	-2560.14
Days Sales Outstanding (DSO)	237.00	124.57	-47.44
Inventory Turnover	-2.33	-0.09	96.24
Debt/Capitalization	0.99	0.95	-3.26
Quick Ratio	0.89	3.10	248.34
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.20	1.21	0.72
Cash	5.63	7.57	34.43
Capex	-0.07	-0.07	-1.52
Free Cash Flow	-3.59	-23.42	-552.53
Revenue	5.55	4.45	-19.82
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.45	3.03	-12.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	33.11	6.15	-81.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating